|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.15 SEK | +1.62% |
|
+6.12% | +32.65% |
BioInvent International AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 15.32 million compared to SEK 20.64 million a year ago. Net loss was SEK 97.16 million compared to SEK 78.34 million a year ago.
Basic loss per share from continuing operations was SEK 1.48 compared to SEK 1.21 a year ago. Diluted loss per share from continuing operations was SEK 1.48 compared to SEK 1.21 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +32.65% | 151M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
BIOINVENT INTERNATIONAL AB 
